The rapid spread of the coronavirus disease 2019 (COVID-19) pandemic owing to a newly identified coronavirus, SARS-CoV-2, originating in Wuhan, China, has resulted in significant morbidity and mortality around the world. Early reports have shown improved clinical outcome and viral clearance with the use of chloroquine and hydroxychloroquine.1,2
HeartRhythm Case Reports Template
Write in a clean editor, then format for HeartRhythm Case Reports in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the HeartRhythm Case Reports format
HeartRhythm Case Reports is a peer-reviewed journal published by Elsevier, covering Cardiac Arrhythmias and Treatments, Cardiac pacing and defibrillation studies, Cardiac electrophysiology and arrhythmias.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, HeartRhythm Case Reports 12 (2023) 45–58.
Formats any DOI in HeartRhythm Case Reports style. No sign-up. |
| Publishes research in | Cardiac Arrhythmias and Treatments Cardiac pacing and defibrillation studies Cardiac electrophysiology and arrhythmias Atrial Fibrillation Management and Outcomes Cardiovascular Syncope and Autonomic Disorders |
| ISSN | 2214-0271 |
| Citation impact (2-yr) | 0.63 |
| h-index | 28 |
| i10-index | 215 |
| Total citations | 8,338 |
| Article processing charge | $1,050 |
| Open access | Yes |
| Top institutions publishing here | Mayo Clinic |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in HeartRhythm Case Reports per year
Citation impact of HeartRhythm Case Reports by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in HeartRhythm Case Reports
First described in the 1990s, the Brugada syndrome initially characterized unexplained sudden cardiac death in healthy Southeast Asian men.1 Mutations in the cardiac sodium channel were later identified in the SCN5A and SCN10A genes, accounting for nearly 50% of the cases.2,3 Brugada syndrome phenotype is associated with decrease in the sodium current owing to reduction…
Key Teaching Points•Ventricular arrhythmia storm is a life-threatening clinical event often requiring immediate intervention. Therapeutic strategies include antiarrhythmic drug therapy, deep sedation, cardiac pacing, catheter ablation, and cardiac assist systems.•Only recently, clinical pilot studies have proven the efficacy of cardiac stereotactic radiotherapy in stabilizing patients with refractory ventricular tachycardia storm.•We here present the first case…
Although transvenous pacemakers and implantable cardioverter-defibrillators (ICD) have long been the standard of care, they are not without significant drawbacks. In recent years, major advances have been achieved in leadless pacemaker technology1 and entirely subcutaneous ICD (S-ICD) systems2 that obviate intracardiac leads and hence carry the potential to reduce associated complications. Unlike standard ICDs, the…
One of the most feared complications of a traditional pacemaker system is cardiac implantable electronic device infection. In such cases, a complete removal of the entire system is recommended.1,2 With the advent of the leadless transcatheter pacemaker system (TPS), the weak link—namely, the pacing leads that contribute to this problem—can be ultimately eliminated. At least…